Clinical Trial Update: A Study to Evaluate the Safety and Immunogenicity of a Single Dose of Adsorbed Tetanus Vaccine in a Population Aged 18 Years and Over [Phase 1]

View source ↗

Summary

Phase 1 study evaluating the safety and immunogenicity of a single-dose adsorbed tetanus vaccine in adults 18 years and older; the trial has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tetanus

Drugs mentioned

• Tetanus Toxoid Vaccine (Adsorbed) (Tetanus toxoid vaccine (adsorbed))

Snippet

Sponsor: CanSino Biologics Inc. | Conditions: Tetanus | Phase 1 | Status: COMPLETED